Trademark: 79260523
Word
JETEMA THE TOXIN
Status Date
Tuesday, August 11, 2020
Registration Number
6121081
Registration Date
Tuesday, August 11, 2020
Filing Date
Tuesday, April 30, 2019
Published for Opposition
Tuesday, May 26, 2020
5 pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for urogenital organs; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; allergy medications; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; analgesics; pharmaceutical preparations for respiratory organs; medicines for dental purposes; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Color is not claimed as a feature of the mark.
"THE TOXIN"
The wording "JETEMA" has no meaning in a foreign language.
Dec 19, 2020
Final Decision Transaction Processed By Ib
Dec 1, 2020
Final Disposition Notice Sent To Ib
Dec 1, 2020
Final Disposition Processed
Nov 11, 2020
Final Disposition Notice Created, To Be Sent To Ib
Aug 11, 2020
Registered-Principal Register
May 29, 2020
Notification Processed By Ib
May 26, 2020
Official Gazette Publication Confirmation E-Mailed
May 26, 2020
Published For Opposition
May 13, 2020
Notification Of Possible Opposition Sent To Ib
May 13, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
May 6, 2020
Notification Of Notice Of Publication E-Mailed
Apr 17, 2020
Assigned To Lie
Apr 8, 2020
Approved For Pub - Principal Register
Apr 7, 2020
Teas/Email Correspondence Entered
Apr 7, 2020
Correspondence Received In Law Office
Apr 7, 2020
Teas Response To Office Action Received
Mar 27, 2020
Refusal Processed By Ib
Feb 19, 2020
Notification Of Non-Final Action E-Mailed
Feb 19, 2020
Non-Final Action E-Mailed
Feb 19, 2020
Non-Final Action Written
Jan 30, 2020
Teas/Email Correspondence Entered
Jan 29, 2020
Correspondence Received In Law Office
Jan 29, 2020
Teas Response To Office Action Received
Jan 29, 2020
Teas Voluntary Amendment Received
Aug 23, 2019
Refusal Processed By Ib
Aug 2, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Aug 2, 2019
Refusal Processed By Mpu
Jul 16, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Jul 15, 2019
Non-Final Action Written
Jul 15, 2019
Non-Final Action (Ib Refusal) Withdrawn For Review
Jul 12, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Jul 11, 2019
Non-Final Action Written
Jul 11, 2019
Assigned To Examiner
Jun 22, 2019
Application Filing Receipt Mailed
Jun 18, 2019
New Application Office Supplied Data Entered In Tram
Jun 13, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
